A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

This study has been completed.

Study NCT00001341 Information provided by National Institutes of Health Clinical Center (CC)

First Received: November 3, 1999 Last Updated: March 3, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	June 2001
Estimated Primary Completion Date:	No date given